High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumour Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort - Sorbye, H; Dragomir, A; Sundström, M (PLoS ONE, 2015)
et al.